Gapping up
In reaction to earnings/guidance:
- M +13.2%, DLTR +12.7%, DG +11.1%, WSM +8.4%, MOD +8%, BKE +7.2%, SPLK +6.7%, BIDU +5.6%, TITN +5.6%, BABA +4.2%, ELF +3.8%, MANU +3.5%, GES +3.4%, ENS +3.1%, BRC +2.5%, JBLU +2% (guidance), LUV +1.5% (guidance), BZUN +1.4%, CHNG +1.1%, CM +0.9%
Other news:
- AKTS +6.1% (suspended sales under its previously-announced "at the market" equity offering program in light of current market conditions)
- RETA +6% (announces FDA filing acceptance and Priority Review Designation for the NDA for omaveloxolone for the treatment of patients with Friedreich's ataxia; PDUFA date November 30 2022)
- TWTR +5.6% (Elon Musk increases commitment in takeover bid to $33.5 bln; also reaches settlement with DOJ and FTC to pay $150 mln in civil penalties for alleged data privacy violations)
- RH +4.2% (in sympathy with WSM earnings)
- W +3.4% (in sympathy with WSM earnings)
- LEGN +3.4% (receives conditional approval for CARVYKTI by the EC)
- BBBY +2.8% (in sympathy with WSM earnings)
- TSLA +1.7% (Elon Musk increases commitment in takeover bid of TWTR to $33.5 bln)
- VMW +1.5% (Broadcom (AVGO) to acquire VMware for ~$61 billion in cash and stock)
- HYLN +1.3% (receives Hypertruck ERX order from Holcim)
- HMN +1% (authorizes new $50 mln share repurchase program)
Analyst comments:
- ALHC +3.8% (upgraded to Buy from Neutral at BofA Securities)
- CI +1.7% (upgraded to Neutral from Underperform at BofA Securities)